PSY26 Healthcare Costs, Resource Utilization, and Adverse Events Associated with Long-term Oral Corticosteroid Use in Patients with Systemic Lupus Erythematosus in the United States

Abstract

To evaluate costs, healthcare resource utilization (HRU), and oral corticosteroid (OCS)-related adverse events (AEs) associated with OCS use >5 mg/day among patients with systemic lupus erythematosus (SLE) who are long-term OCS users (≥12 months’ continuous use) versus nonusers.